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The application of a sensitizing dose of urushiol on a 
dinitrofluorobenzene (DNFB)-treated skin area signifi-
cantly diminished the intensity of the urushiol challenge 
test in guinea pigs. Furthermore, the animals which had 
been first exposed to urushiol through DNFB-treated 
skin failed to become sensitized in a second sensitization 
attempt even when painted on a previously untreated 
area. This tolerance is hapten-specific and may be re-
versed by treatment with cyclophosphamide (200 mg/ 
kg) shortly before another contact sensitization attempt 
to urushiol. In a previous work, we have shown that 
most of the Langerhans cells present in the DNFB-
treated skin area are ATPase-negative and that there 
exists a link between the membranous A TPase system 
and the formation of Langerhans cell granules. The 
latter seem to develop in the course of a mechanism of 
adsorptive pinocytosis during which ATPase activity 
"disappears." Thus we suggest that the "unavailability" 
of ATPase-negative Langer hans cells for adequate proc-
essing of a second hapten may result from the incapacity 
of cells lacking their A TPase system to activate the 
intracellular events that depend on this system and that 
normally lead to sensitization . 
In 1980, Toews et a l [1] s howed that there is-actually for 
certain strains of mice on ly [2] - a correlation between the 
number of ATPase-positive Langerhans cells (LC) and the 
abi li ty to induce contact hypersensitivity. Thus mouse epider-
mis that is deficie n t in ATPase- positive LC- either artificia lly 
(by UVB) or naturally (tai l s kin) - cannot undergo contact 
hypersensitivity to dinitrofluorobenzene (DNFB). In addition, 
as a result of the first in troduction of the hapten through the 
skin area deficient in ATPase-positive LC, the mice become 
tolerant; thus a second sensitization attempt, this time by 
application of DNFB to healthy s kin , is equally unsuccessful. 
This state of to lerance is specific and the same animals actually 
react to contact with another ha pten, provided the latter is 
applied to healthy skin. 
The induction of co ntact hypersensitivity to DNFB also 
causes, in the sens itization zone, a decrease in the density of 
ATPase-positive LC [3]. This drop in our experiments, is 
maximum at the 24th hour [4]. In t his paper, we investigate 
the reaction of the immune system to a sensitizing dose-on 
the sk in area depleted in ATPase-positive LC by the application 
24 h earlier of DNFB- of a second strong hapten: urushiol. 
MATERIALS AND METHODS 
AnimaLs 
Female albino Himalayan spotted guinea pigs, weighing 300- 400 g, 
were used th roughout the experiments. They were kindly supplied by 
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the Institut fur Biologische und Medizinische Forschung, Fiillingsdorf, 
Switzerland. 
Antigens 
2,4-Dinitro-1-fluorobenzene (DNFB, Prolabo, Paris) and urushiol 
(kindly supplied by Dr G. Dupuis, University of Sherbrooke, Canada) 
were used. 
Sensitization and Elicitation of Contact Sensitivity 
Sensitization and elicitation to DNFB: Seven guinea pigs were sen-
sitized to DNFB by a single epicutaneous application of 25 11l of a 0.5% 
DNFB solu tion in acetone:olive oil mixture (4:1). The hapten was 
deposited on a square with 1.5-cm sides on the shaven flank of the 
animals. Elicitation was carried out on day 5 by application- on a 2 
cm2 circular area on the opposite shaven flank- of 25 11l of a 0.2% 
DNFB solut ion in an acetone:ol ive oil mixture (4:1). Skin reactions 
were read 24 h after the challenge. The intensity of the reactions was 
evaluated according to the following scale: no visible change = 0, 
discrete erythema= 0.5, confluent erythema = 1, intense erythema and 
swelling= 2. Two groups of 7 animals each were used as control groups 
for DNFB. One of these groups was sensitized only to DNFB, the other 
to DNFB and 24 h later to urushiol (according to the methods described 
in the following paragraph); the latter hapten was applied on the flank 
opposite to the one on which DNFB had been applied. 
Sensitization. and elicitation to urushiol: The same 7 guinea pigs were 
sensitized to urushiol 24 h after application of DNFB. For the sensiti-
zation, 25 11l of an urushiol solution (1 mg/ 25 111) in acetone was applied 
on the DNFB-treated skin area. Elicitation was carried out 14 days 
later by application- to a 2 cm2 circular area and at some distance 
from the DNFB test, on the opposite shaven flank-of 25 11l of an 
urushiol solu tion (6.5 11g/25 Ill) in acetone. The intensity of the reac-
tions was evaluated 48 h later using the same above mentioned scale. 
Seven guinea pigs, the control group for urushiol, were sensitized only 
to urushiol and tested 14 days later. 
Assessment of Hyporesponsiveness 
To determine whether hyporesponsive animals were tolerant, ani-
mals which showed little or no contact sensitization after initial chal-
lenge-actually the group of animals sensitized to urushiol on a DNFB-
treated skin area-were subjected, the day after reading the test, to a 
second immunizing dose of urushiol (25 11! of an urushiol solution [1 
mg/25 111] in acetone) on a normal skin area. Challenge tests were 
carried out 14 days later by application of 25 11l of an urushiol solution 
(6.5 11g/25 Ill) in acetone on a 2 cm2 circular area. The intensity of the 
reaCtions was determined 48 h later as above. Seven guinea pigs, a 
control group, were twice sensitized to urushiol at an 18-day interval, 
on a different flank each time. 
Statistical Analysis 
The results of our experiments were expressed, in each group, by the 
frequency of decreased or of no responses. The frequencies thus ob-
tained in the experimental group were compared to those observed in 
the control group, using the Fisher exact probability test (in one-tailed 
test). 
RESULTS 
Inhibitory Effect of a Pretreatment of DNFB on Attempted 
Contact Sensitization to Urushiol (Table I) 
All control animals reacted to the challenge test with the 
same strong intensity. Among the 7 animals sensitized to 
urushiol on a DNFB-treated skin area, only 1 showed a chal-
lenge test with the same intensity as the animals of the control 
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TABLE I. Inhibitory effect of a pretreatment by DNFBa on the 
development of contact sensitivity to urw;hiol 
Number of 
anima)s with an 
Group No. of Treatment intensity test• to 
animals urushiol of: 
0.5 0 
Control 7 Sensitization to 7/7 0/7 0/7 
urushiol on 
normal skin 




a Twenty-five microli ters of a 0.5% DNFB solu t ion in acetone:o live 
oil mixture (4:1) was applied to a square with 1.5 em sides, 24 h before 
the sensitization attempt (on t he same area) to urushiol (25 ,.,1 of a 1 
mg/25 ,.,1 solu t ion). 
• Intensity of reactions to urushiol was evaluated, 14 days after the 
sensiti zation attempt, accordi ng to t he following scale: no change= 0, 
discrete erythema= 0.5, con fluent erythema= 1, intense erythema and 
swelling = 2. 
TABLE ll. Induction of hypo- or unresponsiveness to urw;hiola 
Group No. of animais 
Control 7 
Control 7 
Experimenta l 7 
Treatment 
Number of animals 
with an intensity 
test• to urushiol of: 
2 0~ 0 
Sensitization to uru- 7/7 0/7 0/7 
shiol on normal 
skin 
Two sensitizations to 2/7 5/7 0/7 0/7 
urushiol on normal 
skin, at an 18-day 
interval 
First sensitization to 2/7 3/7 2/7 
urushiol on 
DNFB-treated site 
and second on nor-
mal skin 
• Animals were sensitized to urushiol on DNFB-treated skin and 
sensitized aga in, 18 days later, to uru shiol on normal skin . 
• Intensity of reactions to urushiol was evaluated, 14 days after the 
second sensitization attempt, accordin g to the following scale: no 
change = 0, discrete erythema = 0.5, conl1uent erythema = 1, intense 
erythema and swelling = 2. 











Sensitization on ly to 
DNFB 
Number of animals 
with an intensity 
test• to DNFB of: 
2 0.5 0 
7/7 0/7 0/7 0/7 
Sensitization to DNFB 7/7 0/7 0/7 0/7 
and 24 h later, on 
the opposite un -
treated s haven 
flank, to urushiol 
Sensitization to DNFB 6/7 1/7 0/7 0/7 
and 24 h late r, on 
the same area, to 
urushiol 
a The animals sensitized to urushiol on a DNFB-treated skin area 
were tested to DNFB 5 days after application of a sensitizing dose of 
this compound. 
• Intensity of reactions to DNFB was evaluated, 5 days after the 
sensitization procedure, according to the following scale: no change = 
0, discrete erythema = 0.5, conl1uent erythema = 1, intense erythema 
and swelling = 2. 
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group. The other guinea pigs either reacted with a lesser inten -
sity (4 animals) or showed no reaction at all (2 animals) (p < 
1%). 
Induction of Hypo- or Unresponsiveness (Table II) 
The day fo llowing reading of the challenge test for urushiol 
the group of animals sensitized to urushiol on a DNFB-treated 
skin area were again sensitized to urushiol, but this time by 
application of the hapten to normal skin. On reading the tests 
14 days later, 2 animals showed a test with an intensity equally 
observed in the control group, 3 guinea pigs had a lower 
intensity than that of the control group, and 2 animals showed 
no reaction at a ll (p < 1 %). Therefore the animals exposed to 
urushiol through DNFB -treated skin revealed suppressed chal-
lenge reactions to the subsequent sensitization procedure even 
through normal skin. 
Specificity of Unresponsiveness to Urushiol (Table III) 
The animals sensitized to urushiol on a DNFB-treated skin 
area were tested to DNFB 5 days after application of a sensi _ 
tizing dose of this compound. Twenty-four hours after appli-
cation of the challenge test, all showed a reaction with an 
intensity comparable to that observed in the animals sensitized 
only to DNFB or to those animals sensitized to DNFB and 24 
h later, on the opposite untreated flank, to urushiol. Thus the 
induced tolerance to urushiol is specific for this compound and 
does not affect at all sensitization to another hapten. 
Reversal of Unresponsiveness by Cyclophosphamide 
The two tolerant guinea pigs were subjected to an i.p. injec-
tion of cyclophosphamide at a dose of 200 mg/kg. After 3 day:s 
these animals were subjected to a normal sensitization proce~ 
dure to urushiol. They were tested 14 days later and the 
intensity of the tests in these 2 animals was then comparable 
to that of the control group sensitized on ly to urushiol. The 
treatment with cyclophosphamide shortly before sensitization 
therefore seems to have reversed unresponsiveness in toleral)t 
animals. 
DISCUSSION 
In 1980, Ptak et al [5] showed that hapten-conjugated epi-
dermal cells induced a contact allergy in syngeneic mice when 
injected by i.v. , i.p., or s.c. routes. They hypothesized that, "the 
cell type(s) in the skin which are responsible for this potent 
form of antigen preservation are most likely Langerhans cells." 
Numerous publications later confirmed their hypothesis and 
stressed the importance of LC which constitute "the critic<:~J 
determinant in whether exposure to a hapten leads to sensitiv-
ity or to tolerance" [1]. Thus, injection by i.v. or i.p. routes Of 
a LC-depleted epidermal cell suspension (respectively by Ficoll 
gradients or by using mouse anti-Ia antisera and complement) 
not only abrogates the capacity to induce contact sensitization 
but also induces a state of tolerance [6,7]. The same phenom-
enon is observed after s.c. injection of a suspension of epiderm&! 
cells UV -irradiated prior to haptenization [8] or when a hapten 
is applied to UVB-treated skin [1]. The effect of UV radiation 
is complex. From a morphologic point of view, although it 
results in a drop in the number of ATPase-positive LC, electron 
microscopy shows that this is mainly due to a loss of their 
enzymatic ATPase surface markers and that a majority of the 
LC appear morphologically unaltered [9]. From a function&} 
point of view, however, UV radiation "adversely interferes with 
certain steps of antigen processing and possibly with antigen 
uptake by Langerhans cells" [10]. 
The induction of contact sensitization to DNFB also cause~ 
during the 48 h following application of the hapten, as show~ 
by Bergstresser eta! [3], a decrease in the number of ATPase_ 
positive LC in the sensitization zone. In a previous work We 
have repeated this study [3] in the guinea pig, and observed 
during the 5-day "incubation period" separating the first appli-
cation of the hapten from the moment when the animal is 
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sensitized, the fate of the LC in the sensitization zone (manu-
script in preparation). While there sometimes appears an in-
flammatory reaction , the epidermis nevertheless retains its 
integrity from a clinical and histologic point of view. The LC 
count reveals, however, as after UV treatment, a decrease in 
the density of ATPase-positive LC. This decrease, which is not 
observed in response to the excipient alone (acetone:olive oil, 
4:1), varies with time; in our experiments, a maximum was 
reached 24 h after contact sensitization. At this point, the 
density of ATPase-positive LC ranged from 48 to 474/mm2 
with an average of 273 ± 87 /mm2 , as compared to a normal 
mean density of 893 ± 46/mm2 a density which, on the fourth 
day of the incubation period, is observed again on the sensiti-
zation zone. This "absence" of LC causes, as we have shown: 
(1) weak sensitization to urushiol (the variations in the inten-
sity of the challenge test to urushiol - Table 1-could follow 
the variations in the density of ATPase-positive LC at the 24th 
hour) ; (2) hypo- or unresponsiveness to urushiol, most probably 
mediated by suppressor cells as suggested by the results of 
t reatment with cyclophosphamide. 
To complete these light microscope studies of the fate of LC 
in the sensitization zone, we have carried our parallel observa-
tions under the electron microscope after revelation of the 
membranous ATPase activity. Several striking modifications 
of the plasma membrane and cytoplasm of LC were observed, 
in particular: (1) 15 min after applying DNFB, numerous coated 
vesicles appear in t he vicinity of the plasma membrane in a 
few LC; lead sulfide granu lations, evidencing ATPase activity, 
are visible in a few coated pits; (2) 1 h after applying the hapten, 
some LC become ATPase-negative, this loss of ATPase activity 
being accompanied by the formation of numerous LC granules 
in the cytoplasm [ll] ; (3) 24 h after applying DNFB, when the 
density of ATPase-positive LC is at its minimum, there remains 
in the epidermis, apart from a few ATPase-positive LC, a large 
number of ATPase-negative LC separated from keratinocytes 
by spongiosis. 
lt thus appears that in LC a link exists between an adsorptive 
pinocytosis process, t he membrane ATPase system, and the 
appearance of Langerhans granules in the cytoplasm. These 
results differ from those of Ishii et al [12) according to whom, 
in humans, LC granules would form from plasma membrane at 
the same time as coated vesicles; and the granules would be but 
prolongations of the latter. Therefore, it is possible that in the 
absence of the membranous ATPase system, as a result of 
treatment with DNFB 24 h beforehand, the application of 
urushiol does not induce the intracellular events which nor-
mally follow activation of the membranous ATPase system. 
These events could play a vital role in the formation of the 
hapten-carrier protein- Ia antigen complex. In their absence in 
a large number of LC, following destruction (UV irradiation 
[9)) or "disappearance" (epicutaneous application of a hapten) 
of the membranous ATPase system, epicutaneous application 
of a hapten such as urushiol to the ATPase-negative LC would 
lead to the development of a state of immune tolerance. In this 
hypothesis, the fate of the hapten remains undefined; it may in 
fact be captured by the ATPase-negative LC. 
In conclusion, it appears that a specific tolerance may be 
induced by application of a hapten to a skin area in which a 
fair number of LC are either absent naturally (mouse tail skin) 
or artificially (anti-Ia antisera and complement), or are non-
functional, after destruction (UV irradiation) or "disappear-
ance" (processing of a hapten) of the membranous ATPase 
system. 
Addendum 
After our communication to the British Society for Investi-
gative Dermatology (September, 1983) and while revising this 
article, it has come to our attention that similar results had 
been obtained in mice by other authors: Kotake K, Kanagawa 
H, Semma M, Sagami S: J Dermatol (Tokyo) 10:447-453, 1983. 
These workers have shown, as suggested by our results, that 
application, at a 24-h interval, of 2 haptens leads to the ap-
pearance of suppressor T cells specific for the second hapten. 
In addition, they have demonstrated that these suppressor cells 
may be transmitted by i.v. injection of spleen cells in syngeneic 
untreated mice. 
The authors thank Dr Michel Roos, Institut d'Histologie, CHU de 
Strasbourg, for his most valuable help in the statistical evaluations. 
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